OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibiotics in the clinical pipeline as of December 2022
Mark S. Butler, Ian R. Henderson, Robert J. Capon, et al.
The Journal of Antibiotics (2023) Vol. 76, Iss. 8, pp. 431-473
Open Access | Times Cited: 118

Showing 26-50 of 118 citing articles:

Using Machine Learning to Predict the Antibacterial Activity of Ruthenium Complexes**
Markus Orsi, Boon Shing Loh, Cheng Weng, et al.
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 10
Closed Access | Times Cited: 13

The Citizen Phage Library: Rapid Isolation of Phages for the Treatment of Antibiotic Resistant Infections in the UK
Julie Fletcher, Robyn Manley, C. P. Fitch, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 253-253
Open Access | Times Cited: 4

Systematic mapping of antibiotic cross-resistance and collateral sensitivity with chemical genetics
Nazgul Sakenova, Elisabetta Cacace, Askarbek Orakov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

Potent Inhibition of E. coli DXP Synthase by a gem-Diaryl Bisubstrate Analog
Lauren B. Coco, Eucolona M. Toci, Percival Yang-Ting Chen, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1312-1326
Open Access | Times Cited: 3

Cannabinoids from C. sativa L.: Systematic Review on Potential Pharmacological Effects against Infectious Diseases Downstream and Multidrug-Resistant Pathogens
Adriana Ribeiro, Rahaf Alsayyed, Daniele Oliveira, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 590-625
Open Access | Times Cited: 3

The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs
Megan O’Shaughnessy, Orla Sheils, Anne‐Marie Baird
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12296-12296
Open Access | Times Cited: 9

Harnessing Transition Metal Scaffolds for Targeted Antibacterial Therapy
Cheng Weng, Yong Leng Kelvin Tan, Wayne Gareth Koh, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 50
Open Access | Times Cited: 9

Forward or Backward: Lessons Learned from Small Molecule Drugs Approved by FDA from 2012 to 2022
M. Gu, Sudan Sun, Qidong You, et al.
Molecules (2023) Vol. 28, Iss. 24, pp. 7941-7941
Open Access | Times Cited: 8

New Biocides Based on N4-Alkylcytidines: Effects on Microorganisms and Application for the Protection of Cultural Heritage Objects of Painting
Liudmila A. Alexandrova, Ivan A. Oskolsky, Д. А. Макаров, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3053-3053
Open Access | Times Cited: 2

Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase
Nichole K. Stewart, Márta Tóth, Pojun Quan, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1232-1249
Open Access | Times Cited: 2

Antimicrobial activity and cytotoxicity of novel quaternary ammonium and phosphonium salts
Bárbara Nunes, Fernando Cagide, Fernanda Borges, et al.
Journal of Molecular Liquids (2024) Vol. 401, pp. 124616-124616
Open Access | Times Cited: 2

The drug drought in maternal health: an ongoing predicament
Anne Ammerdorffer, Annie R.A. McDougall, Andrew Tuttle, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 7, pp. e1174-e1183
Open Access | Times Cited: 2

Bacterial efflux pump OMPs as vaccine candidates against Multidrug-Resistant Gram-negative bacteria
Thaynara O Silva, Ana Carolina Silva Bulla, Bárbara A Teixeira, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 6, pp. 1237-1253
Closed Access | Times Cited: 2

Beyond Antibiotics: What the Future Holds
Payam Benyamini
Antibiotics (2024) Vol. 13, Iss. 10, pp. 919-919
Open Access | Times Cited: 2

In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin
Toluwase Hezekiah Fatoki, Tosin Christianah Balogun, Adebayo Emmanuel Ojewuyi, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2

Investigating inhibitors of 1-deoxy- d -xylulose 5-phosphate synthase in a mouse model of UTI
Eric C. Chen, Rachel Shapiro, Arindom Pal, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 1

Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations
Darren Bentley
Antibiotics (2024) Vol. 13, Iss. 4, pp. 337-337
Open Access | Times Cited: 1

The twin challenges of longevity and climate change in controlling antimicrobial resistance
Maryam Shafaati, Mohammadreza Salehi, Maryam Zare
The Journal of Antibiotics (2024) Vol. 77, Iss. 7, pp. 399-402
Closed Access | Times Cited: 1

New antibiotics to combat One Health AMR
Abiodun D. Ogunniyi, Henrietta Venter, Mark A. T. Blaskovich
Microbiology Australia (2024) Vol. 45, Iss. 2, pp. 74-78
Open Access | Times Cited: 1

Ultrasound‐mediated antibiotic delivery to in vivo biofilm infections: A Review
Jamie D. Liu, Kelly E. Van Treeck, William A. Marston, et al.
ChemBioChem (2024)
Open Access | Times Cited: 1

Check of APpropriaTeness of Antimicrobial therapy In Nursing homes (CAPTAIN):a point prevalence study in Belgium
Indira Coenen, Lotte Vander Elst, Isabel Spriet, et al.
JAC-Antimicrobial Resistance (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 1

Scroll to top